Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.31 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
| ▸ | LSS | P48449 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3024404 | 0.98 | CA14 (0.48) | CA14ALDH1A1L3MBTL1HDAC6HDAC1 | |
| SCHEMBL8642294 | 0.92 | CA14 (0.42) | CA14ALDH1A1L3MBTL1HDAC6HDAC1 | |
| SCHEMBL8642292 | 0.92 | CA14 (0.42) | CA14ALDH1A1L3MBTL1HDAC6HDAC1 | |
| SCHEMBL4686524 | 0.92 | CA14 (0.42) | CA14ALDH1A1L3MBTL1HDAC6HDAC1 | |
| SCHEMBL8088607 | 0.92 | CA14 (0.42) | CA14ALDH1A1L3MBTL1HDAC6HDAC1 | |
| SCHEMBL17363381 | 0.92 | CA14 (0.46) | CA14ALDH1A1L3MBTL1HDAC6HDAC1 | |
| SCHEMBL17363437 | 0.91 | CA14 (0.43) | CA14ALDH1A1L3MBTL1HDAC6HDAC1 | |
| SCHEMBL25282321 | 0.90 | CA14 (0.41) | CA14ALDH1A1L3MBTL1HDAC6HDAC1 | |
| SCHEMBL15942002 | 0.89 | CA14 (0.42) | CA14ALDH1A1L3MBTL1HDAC6HDAC1 | |
| SCHEMBL17363444 | 0.89 | CA14 (0.40) | CA14ALDH1A1L3MBTL1HDAC6HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100189679-A1 | CROSSLINKED POLYALLYLAMINE OR ACID ADDITION SALT THEREOF, AND USE THEREOF FOR MEDICAL PURPOSES | TORAY INDUSTRIES, INC. (JP) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100189679-A1 | CROSSLINKED POLYALLYLAMINE OR ACID ADDITION SALT THEREOF, AND USE THEREOF FOR MEDICAL PURPOSES | SLC6A12, SLC20A1, SLC20A2 | CA14 705/4885ALDH1A1 1359/4885L3MBTL1 2775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.